SELF-TEST FOR SARS-COV-2 ANTIGEN (CORONAVIRUS) - ANVISA Registration 10345162447

Access comprehensive regulatory information for SELF-TEST FOR SARS-COV-2 ANTIGEN (CORONAVIRUS) in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10345162447 and manufactured by manufacturer not specified. The registration is held by SIEMENS HEALTHCARE DIAGNÓSTICOS LTDA with validity until Jul 11, 2032.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including HANGZHOU ALLTEST BIOTECH CO. LTD, GENRUI BIOTECH INC., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
10345162447
2 Related Devices
Registration Details
ANVISA Registration Number: 10345162447
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Related Devices (2)

Família Autoteste CLINITEST Rapid COVID-19 Antigen
Risk Class III

Registration Details

10345162447

25351060619202238

01449930000190

Company Information

Dates and Status

Jul 11, 2022

11/07/2032

09/18/2025 19:00:01

Família Autoteste CLINITEST Rapid COVID-19 Antigen
Risk Class III

Registration Details

10345162447

25351060619202238

01449930000190

Company Information

United States of America
PT: ESTADOS UNIDOS DA AMÉRICA

Dates and Status

Jul 11, 2022

11/07/2032

09/18/2025 19:00:01